Tapan K. Das PhD

Tapan experience includes biologics analytical method (separations, impurity and other methods) development/validation for release & stability, GMP stability, GMP testing, Protein structure-function, Critical quality attribute (CQA), Analytics for DS and DP process & formulation development, Manufacturing investigation, New technology development; Regulatory filing; biologics characterization, higher order structure tools including biophysical, HDXMS and protein particulates, and analytical program management. Prior to joining BMS, he was at Pfizer Biotherapeutics R&D group. He has 80+ publications (peer-reviewed journal articles and patents).